Pharmaceutical Industry Information Portal

HomeNews

News

Taiwan OBI Pharma enters license agreement with China Odeon Therapeutics

OBI Pharma, Inc. and Odeon Therapeutic, the biopharma companies, have entered into an exclusive license agreement whereby OBI grants rights of OBI-999, a novel...

A major pharmaceutical company Eli Lilly suspends Russia investments, will continue sale of essential drugs

US drugmaker Eli Lilly is scaling back business in Russia, but still pledge to continue supplying critical medicines. Lilly said it will send medicines for...

Italian Stevanato Group expands the boundaries by opening a manufacturing hub in China

The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today...

FDA approves new version of Philips Capsule Surveillance solution

Royal Philips, a global leader in health technology, announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510(k) market...

Merck’s proposal to combine two top prostate cancer drugs fails

Merck (MSD) on Tuesday announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with LYNPARZA, a...

illumina launches multiple-gene test to spot rare treatable cancers

Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal...
spot_img

Expert Articles

spot_img